The prevalence of extramedullary acute myeloid leukemia detected by 18FDG-PET/CT: final results from the prospective PETAML trial

Extramedullary (EM) disease in patients with acute myeloid leukemia (AML) is a known phenomenon. Since the prevalence of EM AML has so far only been clinically determined on examination, we performed a prospective study in patients with AML. The aim of the study was to determine the prevalence of me...

Полное описание

Библиографические подробности

Главные авторы:	Friedrich Stölzel, Tors Lüer, Steffen Löck, Stefani Parmentier, Friederike Kuithan, Michael Kramer, Nael S. Alakel, Katja Sockel, Franziska Taube, Jan M. Middeke, Johannes Schetelig, Christoph Röllig, Tobias Paulus, Jörg Kotzerke, Gerhard Ehninger, Martin Bornhäuser, Markus Schaich, Klaus Zoephel
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Ferrata Storti Foundation 2020-06-01
Серии:	Haematologica
Online-ссылка:	https://haematologica.org/article/view/9430
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!